Dentsply Sirona, Inc. (NASDAQ: XRAY)
On August 9, 2017, Dentsply Sirona announced in its Form 10-Q filing that the SEC’s Division of Enforcement “has asked the Company to provide documents and information concerning the Company’s accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company.” In reaction, Dentsply Sirona’s share price fell $5.18, or 8.4%, to close at $56.23 on August 9, 2017.
On October 2, 2017, Dentsply Sirona announced that three top executives tendered their resignations: CEO Jeffrey Slovin, Executive Chairman Bret Wise, and President and Chief Operating Officer Christopher Clark. This news drove the price of Dentsply Sirona shares down $3.48, or 5.8%, to close at $56.33 on October 2, 2017.
The next day, The Wall Street Journal reported the Company’s board forced these executives out.
“We’re focused on the matters triggering the SEC’s inquiry, the extent of improper accounting if any, and the possible roles of the recently-departed executives,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.